Pacira BioSciences Inc. (PCRX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q1 2024 | |||||
| ≡ | First Eagle Investment Management | Sell 100.00% | 103,081 | 0.01 | |
| Q4 2023 | |||||
| ≡ | First Eagle Investment Management | Reduce 50.35% | 104,551 | 0.01 | |
| Q3 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 5,823 | 0.00 | |
| ≡ | First Eagle Investment Management | Reduce 15.00% | 36,640 | 0.00 | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 1,108 | 0.00 | |
| Q2 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 48,159 | 0.03 | |
| Q1 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 52.42% | 53,060 | 0.03 | |
| Q4 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 41.28% | 71,161 | 0.05 | |
| Q2 2016 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 1,610,932 | 1.35 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.